| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HERON THERAPEUTICS INC COM | 8,654,914 | 129,824,000 | 46.92% | ||
| 2 | LA JOLLA PHARMACEUTICAL CO | 3,440,419 | 102,697,000 | 37.12% | ||
| 3 | IGNYTA INC COM | 3,972,800 | 34,166,000 | 12.35% | ||
| 4 | BIOMARIN PHARMACEUTICAL INC | 90,215 | 7,919,000 | 2.86% | ||
| 5 | CYCLACEL PHARMACEUTICALS INC | 559,900 | 2,060,000 | 0.74% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-17-003412, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
